5:07 PM ET
8-K
Regulatory Approval
Equillium Regulatory Approval
Equillium received clearance from the Therapeutic Goods Administration in Australia under the Clinical Trial Notification scheme to initiate a Phase 1 clinical trial of EQ504. The study will evaluate the safety and pharmacokinetics of the oral drug in healthy participants, with dosing expected to begin in early November 2026.